Raymond James Financial
MLAB icon

Raymond James Financial’s Mesa Laboratories MLAB Stock Holding History

Raymond James Financial’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9M Buy
149,937
+27,026
+22% +$2.72M ﹤0.01% 1795
2026
Q1 		$10.7M Buy
122,911
+22,514
+22% +$1.94M ﹤0.01% 1964
2025
Q4 		$7.89M Buy
100,397
+52,995
+112% +$4.03M ﹤0.01% 2153
2025
Q3 		$3.18M Sell
47,402
-138,153
-74% -$9.94M ﹤0.01% 2809
2025
Q2 		$17.5M Sell
185,555
-78,458
-30% -$8.61M 0.01% 1474
2025
Q1 		$31.3M Buy
264,013
+16,218
+7% +$2.21M 0.01% 995
2024
Q4 		$32.7M Buy
+247,795
New +$30.4M 0.01% 976

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raymond James Financial's MLAB Position: Q2 2026 in Review

Raymond James Financial increased its Mesa Laboratories (MLAB) stake by 22% in Q2 2026, buying an estimated $2.72M and bringing the position to 149,937 shares worth $14.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1795.

Raymond James Financial first reported a position in MLAB in Q4 2024 and has held it in 7 quarters since. The position peaked at $32.7M in Q4 2024. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Raymond James Financial held 149,937 shares of Mesa Laboratories worth $14.9M as of Q2 2026.
  • Raymond James Financial bought 27,026 Mesa Laboratories shares in Q2 2026, an estimated $2.72M.
  • Mesa Laboratories made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #1795 holding.
  • Raymond James Financial first reported a position in Mesa Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Mesa Laboratories position peaked at $32.7M in Q4 2024.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.